National Human Genome Research Institute; Notice of Closed Meeting, 56430 [2022-19872]
Download as PDF
<![CDATA[
56430
Federal Register / Vol. 87, No. 177 / Wednesday, September 14, 2022 / Notices
Davis Drive, Durham, NC 27709 (Virtual
Meeting).
Contact Person: Varsha Shukla, Scientific
Review Officer, Scientific Review Branch,
Division of Extramural Research and
Training, National Institute of Environmental
Health Sciences, 530 Davis Drive, Keystone
Building, Room 3094, Durham, NC 27713,
984–287–3288, Varsha.shukla@nih.gov.
Name of Committee: Environmental Health
Sciences Review Committee.
Date: November 8–9, 2022.
Time: 11 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Environmental
Health Sciences, Keystone Building, 530
Davis Drive, Durham, NC 27709 (Virtual
Meeting).
Contact Person: Varsha Shukla, Scientific
Review Officer, Scientific Review Branch,
Division of Extramural Research and
Training, National Institute of Environmental
Health Sciences, 530 Davis Drive, Keystone
Building, Room 3094 Durham, NC 27713,
984–287–3288, Varsha.shukla@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.115, Biometry and Risk
Estimation—Health Risks from
Environmental Exposures; 93.142, NIEHS
Hazardous Waste Worker Health and Safety
Training; 93.143, NIEHS Superfund
Hazardous Substances—Basic Research and
Education; 93.894, Resources and Manpower
Development in the Environmental Health
Sciences; 93.113, Biological Response to
Environmental Health Hazards; 93.114,
Applied Toxicological Research and Testing,
National Institutes of Health, HHS.)
Dated: September 9, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–19872 Filed 9–13–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
National Human Genome Research
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Group Pathophysiology of Eye Disease—2
Study Section.
Date: October 13–14, 2022.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites—Chevy Chase
Pavilion, 4300 Military Road NW,
Washington, DC 20015.
Contact Person: Cibu Paul Thomas, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1011–H,
Bethesda, MD 20894, (301) 402–4341,
thomascp@mail.nih.gov.
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Dated: September 9, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–19884 Filed 9–13–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
khammond on DSKJM1Z7X2PROD with NOTICES
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel; Genetic Counselors R25.
Date: December 2, 2022.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute for Human
Genome Research, National Institutes of
Health, 6700B Rockledge Drive, Suite 300,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sarah Jo Wheelan, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute for Human
Genome Research, National Institutes of
Health, 6700B Rockledge Drive, Suite 300,
Bethesda, MD 20892, (301) 435–1580,
wheelansj@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
VerDate Sep<11>2014
18:31 Sep 13, 2022
Jkt 256001
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
Group Aging Systems and Geriatrics Study
Section.
Date: October 13–14, 2022.
Time: 9:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Roger Alan Bannister,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1010–D,
Bethesda, MD 20892, (301) 435–1042,
bannisterra@csr.nih.gov.
Name of Committee: Risk, Prevention and
Health Behavior Integrated Review Group
Lifestyle Change and Behavioral Health
Study Section.
Date: October 13–14, 2022.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Pamela Jeter, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 10J08,
Bethesda, MD 20892, (301) 827–6401,
pamela.jeter@nih.gov.
Name of Committee: Biology of
Development and Aging Integrated Review
Group Drug Discovery and Molecular
Pharmacology Study Section.
Date: October 17–18, 2022.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, 1 Bethesda
Metro Center, Bethesda, MD 20814.
Contact Person: Jeffrey Smiley, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6194,
MSC 7804, Bethesda, MD 20892, 301–594–
7945, smileyja@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Special
Topics: Noninvasive Neuromodulation and
Neuroimaging Technologies.
Date: October 18–19, 2022.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Pablo Miguel Blazquez
Gamez, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (301) 435–1042,
pablo.blazquezgamez@nih.gov.
Name of Committee: Molecular, Cellular
and Developmental Neuroscience Integrated
Review Group Neurodifferentiation,
Plasticity, Regeneration and Rhythmicity
Study Section.
Date: October 19–20, 2022.
Time: 9:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Alexandria Old Town, 1767
King Street, Alexandria, VA 22314.
E:\FR\FM\14SEN1.SGM
14SEN1
]]>Agencies
[Federal Register Volume 87, Number 177 (Wednesday, September 14, 2022)]
[Notices]
[Page 56430]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-19872]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Human Genome Research Institute; Notice of Closed
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Human Genome Research Institute
Special Emphasis Panel; Genetic Counselors R25.
Date: December 2, 2022.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute for Human Genome Research, National
Institutes of Health, 6700B Rockledge Drive, Suite 300, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Sarah Jo Wheelan, Ph.D., Scientific Review
Officer, Scientific Review Branch, National Institute for Human
Genome Research, National Institutes of Health, 6700B Rockledge
Drive, Suite 300, Bethesda, MD 20892, (301) 435-1580,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human
Genome Research, National Institutes of Health, HHS)
Dated: September 9, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-19872 Filed 9-13-22; 8:45 am]
BILLING CODE 4140-01-P
